The anti-lipopolysaccharide factor isoform 3 (ALFPm3), the antimicrobial peptide from Penaeus monodon, possesses antibacterial and antiviral activities. Although the mechanism of action of ALFPm3 against bacteria has been revealed but its antiviral mechanism is still unclear. To further study how the ALFPm3 exhibits antiviral activity against the enveloped virus, white spot syndrome virus (WSSV), the ALFPm3-interacting proteins from WSSV were sought and identified five ALFPm3-interacting proteins, WSSV186, WSSV189, WSSV395, WSSV458, and WSSV471. Only the interaction between ALFPm3 and WSSV189, however, has been confirmed to be involved in anti-WSSV activity of ALFPm3. Herein, the interactions between ALFPm3 and rWSSV186, rWSSV395, rWSSV458, or rWSSV471 were further analyzed and confirmed by in vitro pull-down assay. Western blot analysis and immunoelectron microscopy showed that the uncharacterized proteins, WSSV186 and WSSV471, were nucleocapsid and envelope proteins, respectively. The decrease of shrimp survival after injection the shrimp with mixtures of each rWSSV protein, rALFPm3 and WSSV as compared to those injected with rALFPm3-neutralizing WSSV was clearly observed indicating that all rWSSV proteins could interfere with the neutralization effect of rALFPm3 on WSSV similar to that reported previously for WSSV189. Morphological change on WSSV after incubation with rALFPm3 was observed by TEM. The lysed WSSV virions were clearly observed where both viral envelope and nucleocapsid were dismantled. The results lead to the conclusion that the ALFPm3 displays direct effect on the viral structural proteins resulting in destabilization and breaking up of WSSV virions.
Introduction
Anti-lipopolysaccharide factors (ALFs) are antimicrobial peptides with broad antimicrobial activities toward Gram-positive and Gram-negative bacteria, filamentous fungi and viruses . The ALFs are amphipathic peptides that contain a LPS-binding domain (LPS-BD) within a conserved disulfide bridge. This stable disulfide loop harbors either a highly conserved cluster of positively charged (Lys and Arg) residues or negatively charged (Glu and Asp) and hydrophobic residues (Li et al., 2008; Somboonwiwat et al., 2005; Yang et al., 2009 ). The LPS-BD contributes mainly to the ALF antimicrobial activity.
In Penaeus monodon, six different isoforms of ALF (ALFPm1-6) have previously been reported (Ponprateep et al., 2012; Tassanakajon et al., 2006) , of which the major isoform is ALFPm3. Recombinant ALFPm3 (rALFPm3) exhibits a broad antimicrobial activity spectrum with antifungal property against filamentous fungi, and antibacterial activities against both Gram-positive and Gram-negative bacteria with a high potency against the natural shrimp pathogens, Vibrio harveyi and Vibrio parahaemolyticus AHPND causing early mortality syndrome (Somboonwiwat et al., 2005; Supungul et al., 2015) . In addition, the antiviral property of ALF against the major shrimp viral pathogen, White Spot Syndrome Virus (WSSV), was first reported in the freshwater crayfish Pacifastacus leniusculus (Liu et al., 2006) . Subsequently, the rALFPm3 has been shown to inhibit WSSV propagation in crayfish hematopoietic cell culture and in shrimp (Tharntada et al., 2009) . Moreover, silencing of the ALFPm3 gene in normal shrimp increased the cumulative mortality to 86% in 7 days. The bacterial counts after 2 days of dsRNA-ALFPm3 injection grew by 12-and 50-fold when compared with those of the control in the haemolymph and hepatopancreas, respectively (Ponprateep et al., 2012) . It has been reported that the ALFPm3 effectively kills bacteria through bacterial membrane permeabilization (Jaree et al., 2012) . How the ALFPm3 displays anti-WSSV activity, however, is still a mystery.
Innate immunity in shrimp has been studied intensively to understand the response to viral infection in shrimp and several WSSV-binding proteins have been identified in shrimp (Sritunyalucksana et al., 2013) . Viral-binding proteins are categorized into two types based on the interaction with the virus, specific interaction and non-specific interaction. Several host WSSVbinding proteins with specific interactions have been reported such as PmRab7, PlgC1qR, WSSV-binding protein (WBP), and PmFKBP46. The endosomal protein from the hemocytes of P. monodon, PmRab7, was identified as VP28-binding protein . The PmRab7 gene silencing resulted in the decrease in WSSV replication suggesting that the PmRab7 functions as an important regulator of intracellular trafficking (Ongvarrasopone et al., 2008) . The PlgC1qR, a receptor for globular head domain of complement component C1q, can bind to VP15, VP26, and VP28 of WSSV and possibly plays a role in controlling antiviral mechanism (Watthanasurorot et al., 2010) . Interaction between VP26, a major tegument protein of WSSV, with shrimp cytoskeletal protein b-actin and 3 kDa WSSV-binding protein (WBP) is identified and its important role in WSSV infection is also revealed (Liu et al., 2011; Xie and Yang, 2005; Youtong et al., 2011) . The interaction between a major nucleocapsid protein of WSSV like VP15 with PmFKBP46 has been described and thought to be involved in genome packaging during virion assembly (Sangsuriya et al., 2011) . On the other hand, the non-specific interacting proteins like hemocyanin can bind to WSSV virions and act as antiviral factors of P. monodon (Zhang et al., 2004) .
Previously, yeast-two hybrid screening was performed to elucidate the anti-WSSV action of ALFPm3 (Suraprasit et al., 2014) . Several WSSV proteins such as WSSV186, WSSV189, WSSV395, WSSV458, and WSSV471 could interact with ALFPm3 but only WSSV189 was characterized, leaving the other WSSV proteins for further studies. The identified ALFPm3-interacting proteins such as WSSV186 and WSSV471 were further characterized by Western blot analysis and immunoelectron microscopy (IEM). The aim of this study, therefore, is to elucidate how the ALFPm3 acts on WSSV. The protein-protein interaction between the viral proteins, WSSV186, WSSV395, WSSV458, and WSSV471, and ALFPm3 was confirmed using in vitro pull-down assay. The WSSV-neutralizing activity of the rALFPm3 after pre-incubation of each WSSV protein with ALFPm3 was tested in order to further prove the genuine interaction between the ALFPm3 and these WSSV proteins. In addition, the demolishing of the WSSV virion by rALFPm3 was also studied by IEM.
Materials and methods

Shrimp and WSSV challenge
The P. monodon (average weight of 4e6 g) were purchased from a local shrimp farm in Chachoengsao province, Thailand. The shrimp were acclimatized in the laboratory aquaria at 28 ± 4 C and a salinity of 15 ppt for at least 2 weeks before use in each experiment.
The WSSV stock for the experimental infection was prepared according to the method described by Xie and Yang, 2005 and diluted with the TN buffer (20 mM Tris-HCl pH 7.4 and 400 mM NaCl). One microliter of WSSV stock was serially diluted with the TN buffer to 1 Â 10 À9 dilution. Fifty microliters of the diluted WSSV was injected into the second abdominal segment of the shrimp. This dosage resulted in 100% shrimp mortality within 5 days (data not shown).
Expression and purification of recombinant proteins
In this research, four recombinant ALFPm3-interacting proteins from WSSV, WSSV186 (rWSSV186), WSSV395 (rWSSV395), WSSV458 (rWSSV458), and WSSV471 (rWSSV471) were expressed in the Escherichia coli expression system and purified as described in supplementary data. The purified rALFPm3 protein was prepared according to the method described by Suraprasit et al., 2014. To produce the WSSV proteins tagged with 6 Â His-tag (rWSSV186, rWSSV395, rWSSV458, and rWSSV471), each recombinant clone was constructed. Expression and purification of each rWSSV protein with hexahistidine (His6) at its N-terminus were carried out under native conditions as previously described (Suraprasit et al., 2014) . The rWSSV186 and rWSSV395 proteins were dialyzed and further purified using DEAE Sepharose fast flow (GE Healthcare). The fractions containing the expected recombinant WSSV proteins were pooled. The purified proteins were finally dialyzed against 20 mM Tris-HCl pH 7.4. Five hundred micrograms of purified rWSSV186 and rWSSV471 proteins were used to immunize a mouse for polyclonal antibody production at the Biomedical Technology Research Unit, Chiang Mai University, Thailand.
In vitro pull-down assay
In vitro pull-down assays were modified on the basis of described protocols (Suraprasit et al., 2014) . For one in vitro reaction, 300 mg of rWSSV395 protein was incubated with DEAE Sepharose fast flow (GE Healthcare) at 4 C for 1 h with gentle rocking motion on a rotating platform with the DEAE beads preequilibrated with the wash solution (50 mM Tris-HCl, pH 7.4 containing 200 mM NaCl). Excess rWSSV395 was removed by centrifugation. Then, 30 mg of the rALFPm3 protein, the prey protein, was incubated in rWSSV395 bound-DEAE beads at 4 C for 1 h with gentle rocking motion. The unbound rALFPm3 was removed from the column by centrifugation. The protein-protein complex of rALFPm3 and rWSSV395 was eluted by adding 150 ml of the elution buffer (50 mM Tris-HCl, pH 7.4 containing 500 mM NaCl) and incubated with gentle rocking motion at 4 C for 1 h. Following centrifugation, the protein-protein complex fraction was collected. For other in vitro reactions, each rWSSV (rWSSV186, rWSSV458, and rWSSV471) was tested using Ni Sepharose 6 Fast Flow bead (GE Healthcare). The Ni beads were equilibrated with wash solution (50 mM Tris-HCl, pH 7.2 and 150 mM NaCl containing 40 mM imidazole). After immobilization of rWSSV proteins and rALFPm3 incubation, as described above, the protein-protein complexes of rALFPm3 and rWSSVs were eluted by adding 150 ml elution buffer (50 mM Tris-HCl, pH 7.2 and 150 mM NaCl containing 500 mM imidazole).
To check the ALFPm3-WSSV interaction, Western blot analysis was performed using polyclonal anti-WSSV antisera for rWSSV186, rWSSV458, and rWSSV471 and anti-His antibody (EMD Millipore) for rWSSV395 as a primary antibody and horseradish peroxidaseconjugated goat anti-mouse IgG (EMD Millipore) as a secondary antibody at the dilution of 1:5000 and 1:10,000, respectively. For rALFPm3 detection, the polyclonal anti-rALFPm3 antiserum was used as a primary antibody and alkaline phosphatase-conjugated goat anti-rabbit IgG (EMD Millipore) as a secondary antibody at the dilution of 1:10,000 and 1:10,000, respectively. The bait control column used was the DEAE beads or Ni beads incubated under the same condition as above except that the rALFPm3 incubation was omitted. The prey control column used was similar to the experiment for the protein-protein complex assay but each rWSSV protein was omitted.
Localization of structural proteins on WSSV virion
The purified WSSV used for the localization experiments were provided by Dr. Han Ching Wang, National Cheng Kung University, Tainan, Taiwan. It was prepared from crayfish, Procambarus clarkii, as described by Xie and Yang, 2005. To localize the WSSV proteins, intact WSSV virions were fractionated into envelope and nucleocapsid parts by treatment with Triton X-100 (Tsai et al., 2004) . Ten micrograms of purified WSSV virions and protein fraction of envelope and nucleocapsid were separated on 12.5% SDS-PAGE. The WSSV186 and WSSV471 proteins were detected by Western blot analysis. The membrane was incubated with purified polyclonal mouse anti-WSSV186 (1:5000) and -WSSV471 (1:5000) antibodies as primary antibodies at 4 C overnight. Then, it was incubated with horseradish peroxidaseconjugated goat anti-mouse IgG, the secondary antibody, at the dilution of 1:5000 for 1 h at room temperature. Western Lightning ® Plus-ECL (Perkin Elmer, Inc.) was applied for protein detection by chemiluminescence.
Immunoelectron microscopy (IEM)
Ten microliter aliquots of purified WSSV virion suspension prepared from P. clarkii were adsorbed to the Formvar-supported, carbon-coated nickel grids (300 mesh) for 5 min at room temperature, and the excess solution was removed. The grids were blocked with the blocking buffer (5% bovine serum albumin, 5% normal goat serum, 0.1% cold-water fish skin gelatin (Aurion), 10 mM phosphate buffer pH 7.4 and 150 mM NaCl) for 30 min (Suraprasit et al., 2014) .
Prior to incubation with the primary antibody, the grids were incubated with incubation buffer (0.1% Aurion BSA-c, 15 mM NaN 3 , 10 mM phosphate buffer pH 7.4 and 150 mM NaCl) for 5 min. Either the purified mouse anti-WSSV186 polyclonal antibody or the purified mouse anti-WSSV471 polyclonal antibody diluted 1:40 in the incubation buffer were added and incubated for 2 h at room temperature. As a control, an additional grid containing WSSV virions was incubated with a dilution of preimmune mouse serum. After three washes with the incubation buffer, the grids were incubated for 1 h at room temperature with a goat anti-mouse secondary antibody conjugated with 18-nm-diameter gold particles (1:100 dilution in the incubation buffer). The grids were then washed three times with incubation buffer, then with distilled water to remove the excess salt, and stained with 1% phosphotungstic acid pH 7.2 for 4 min. Specimens were examined with a transmission electron microscope (JEOL JEM-1400 electron microscope).
Topology prediction and 3D models
The amino acid sequences for WSSV186 (accession no. AAL89054), WSSV189 (accession no. AAL89057), WSSV395 (accession no. AAL89263), WSSV458 (accession no. AAL89326), and WSSV471 (accession no. AAL89339) were downloaded from GenBank (http://ncbi.nlm.nih.gov). The web-versions of four different topology prediction methods were used to model the five structural proteins: SOSUI (http://harrier.nagahama-i-bio.ac.jp/sosui/), TMHMM (http://www.cbs.dtu.dk/services/TMHMM-2.0/), TMpred (http://www.ch.embnet.org/software/TMPRED_form.html), and DAS (http://www.sbc.su.se/~miklos/DAS/). Based on the interaction data between WSSV proteins from Sangsuriya et al., 2014 , graphics of the 3D model of the viral protein complex were drawn.
Neutralizing activity
In these experiments, 10 shrimp of 3e5 g body weight were used for each group. For the WSSV-infected control group, 50 ml purified WSSV in TN buffer with a final concentration of 1 Â 10 À9 was injected into the second abdominal segment of the shrimp. Control shrimp were injected with TN buffer only. The test groups were incubated with mixtures of rWSSV proteins and rALFPm3 at 1:1 M ratio for 10 min and then incubated with an equal concentration of WSSV for another 30 min before being injected into the shrimp. In order to prove that the rWSSV proteins used here have no effect on WSSV infection, shrimp were injected with purified WSSV pre-incubated with the same concentrations of rWSSV proteins used in the test groups for 30 min.
The glutathione-S-transferase (GST) protein was used in place of rWSSV proteins as a control protein for the test group. The survival of shrimp was observed every 12 h post WSSV infection for the duration of 10 days. The experiment was performed in triplicate. The flowchart showing the experimental groups are shown in Fig. 1. 
Transmission electron microscopy (TEM)
The effect of rALFPm3 treatment on WSSV virions was observed using transmission electron microscope (TEM). Ten microliter aliquots of purified WSSV virion suspension were incubated with 0, 1, 10, 100, and 250 nM rALFPm3 on carbon-coated cobalt grids (300 mesh) for 10 min at room temperature. The grids were stained with 1% phosphotungstic acid (PTA) pH 7.2. Samples grids were examined with a TEM (JEOL JEM-1400 electron microscope). The GST protein at a final concentration of 250 nM was used as a control.
Results
Expression and purification of recombinant WSSV proteins (rWSSV) and the recombinant ALFPm3 protein (rALFPm3)
To confirm the interaction between rALFPm3 and rWSSV proteins, the recombinant proteins including rWSSV186, rWSSV395, rWSSV458, and rWSSV471 were produced in E. coli expression system. The crude proteins were purified using Ni-NTA for rWSSV458 and WSSV471 and both Ni-NTA and DEAE for rWSSV186 and rWSSV395. The results showed that the purified rWSSV186 ( Fig. 2A), rWSSV395 (Fig. 2B), rWSSV458 (Fig. 2C) , and rWSSV471 (Fig. 2D ) proteins were detected with the expected size of about 58, 38, 26, and 20 kDa, respectively.
On the other hand, the rALFPm3 was produced from Pichia pastoris expression system, purified and shown to have the expected size of about 11.3 kDa (data not shown). Antibacterial activity against Escherichia coli 363 and Bacillus megaterium of the purified-rALFPm3 protein was tested and shown to have the minimum inhibitory concentration (MIC) values of 0.095e0.19 and 0.19e0.39 mM, respectively (data not shown). The purified ALFPm3 protein was used for the in vitro pull-down assay and the study on the binding effect of rWSSV proteins on WSSV-neutralizing activity of rALFPm3.
Protein-protein interaction assay between rWSSV proteins and rALFPm3 by in vitro pull-down assay
The interaction of ALFPm3 with five WSSV proteins including WSSV186, WSSV189, WSSV395, WSSV458, and WSSV471 was identified by yeast two-hybrid screening (Suraprasit et al., 2014) . However, the protein-protein interaction was confirmed for only the WSSV189. In this experiment, the protein-protein interaction between the rest of WSSV proteins and ALFPm3 was further confirmed by using in vitro pull-down assay. As shown in Fig. 3 , the Ni-NTA bead or DEAE bead effectively pulled-down the proteinprotein complexes of rWSSV proteins with rALFPm3 including rWSSV186 (Fig. 3A) , rWSSV395 (Fig. 3B), rWSSV458 (Fig. 3C) , and rWSSV471 (Fig. 3D) . The results indicated that all the rWSSV proteins could specifically bind to rALFPm3 in vitro. Fig. 1 . The experimental design for neutralization activity assay. Eight groups of shrimp were injected with pre-incubated solutions under the conditions described. The rALFPm3, rALFPm3-rWSSV (1:1 by mole), TN buffer, rWSSV, rALFPm3-rGST (1:1 by mole), or rGST mixture were incubated at room temperature for 10 min then 50 ml of 1 Â 10 À9 diluted WSSV was added to the protein mixtures and incubated at room temperature for 30 min except only the rGST or TN buffer control that was incubated at room temperature for 40 min. After pre-incubating, the mixtures were injected into the tested shrimp groups, 10 shrimp per group. The survival rate was observed every 12 h after WSSV infection for 10 days. Fig. 2 . SDS-PAGE and Western blot analysis of the purified recombinant WSSV proteins. The purified rWSSV proteins including rWSSV186 (A), rWSSV395 (B), rWSSV458 (C), and rWSSV471 (D) were separated by 15% coomassie blue stained-SDSePAGE (Lane 1) and analyzed by Western blot analysis (Lane 2) using the polyclonal anti-His antibody as a primary antibody and the goat anti-mouse IgG antibody conjugated with alkaline phosphatase as secondary antibody. Lane M is the protein molecular weight marker.
Localization of WSSV186 and WSSV471 on WSSV
Among the ALFPm3-interacting proteins, WSSV189 and WSSV395 are characterized as envelope proteins, and WSSV458 is known as a tegument protein (Jaree et al., 2016; Suraprasit et al., 2014; Zhu et al., 2006) . Previously, WSSV186 and WSSV471 were identified as WSSV structural proteins (Tsai et al., 2004) ; however, the locations of these proteins were still unknown. Here, the localization of WSSV186 and WSSV471 proteins were investigated on the intact virions, envelope and nucleocapsid protein fractions of WSSV by Western blot analysis using purified WSSV186-and WSSV471-polyclonal antibodies. The VP28, the known envelope protein, was used as a marker for WSSV fractionation.
The result revealed that the WSSV186 protein was detected on the intact WSSV and nucleocapsid fraction. The WSSV471 protein was detected on the intact WSSV and envelope fraction (Fig. 4A) . Moreover, the immumoelectron microscopy technique was performed to confirm the locations of these WSSV proteins. The electron micrograph showed that the position of gold particle-labeled-WSSV186 protein was located on the nucleocapsid part of WSSV. The position of gold particle-labeled-WSSV471 protein was located on the envelope part of WSSV (Fig. 4B) . Therefore, we conclude here that the WSSV186 is a nucleocapsid protein whereas the WSSV471 is an envelope protein.
Binding effect of the rWSSV186, rWSSV395, rWSSV458, and rWSSV471 proteins on the WSSV-neutralizing activity of rALFPm3 protein
To test the significance of the WSSV protein-ALFPm3 interaction, the WSSV proteins were tested against the neutralization activity of ALFPm3 on WSSV. Herein, each rWSSV-rALFPm3 protein mixture was injected along with WSSV into the shrimp. Then, the survival of shrimp was observed (Fig. 6) .
For the shrimp injected with only TN buffer, no shrimp died during the observation period of 10 days. The WSSV pre-incubated with rWSSV186, rWSSV395, rWSSV458, or rWSSV471 also killed the shrimp like injected with WSSV alone. This indicated that all exogenous rWSSV proteins had no effect on WSSV infectivity. In this experiment, recombinant GST protein was used as control. Injection of GST with either WSSV alone or rALFPm3-WSSV mixture, did not affect to the WSSV infectivity and rALFPm3 activity (Fig. 6E) .
In WSSV-infected shrimp, the percentage of shrimp survival decreased to 0% within 5 days. On the other hand, WSSV neutralized with rALFPm3 group, shrimp survived about 20% after day 10 of WSSV infection. In the experimental groups, pre-incubation of rWSSV186 (Fig. 6A), rWSSV395 (Fig. 6B), rWSSV458 (Fig. 6C) , and rWSSV471 ( Fig. 6D) with the rALFPm3 diminished the WSSVneutralizing activity of the rALFPm3 protein; a 0% survival was observed in 7e9 days.
Effect of rALFPm3 treatment on WSSV virions
To investigate the effect of rALFPm3 treatment on WSSV virions, the WSSV was incubated with various concentrations of rALFPm3 protein (1, 10, 100, and 250 nM) and then examined under TEM. Treating the WSSV with the rALFPm3 resulted in the breakage of the envelope of WSSV virions (Fig. 7) . The higher the concentration of rALFPm3 used, the more extensive the level of WSSV virion Fig. 3 . In vitro pull-down assay of protein-protein interaction between the WSSV proteins and rALFPm3. The rWSSV186 (A), rWSSV395 (B), rWSSV458 (C), or rWSSV471 (D) was assayed for their binding to the rALFPm3. The protein-protein complexes were separated by 15% SDS-PAGE and analyzed by Western blotting using anti-His antibody for rWSSV395 and antibody specific to rWSSV186, rWSSV458, rWSSV471, and rALFPm3. damage was observed. As compared to the control, the envelope of WSSV virions was tattered and the WSSV became naked; only nucleocapsid was observed. Furthermore, the morphology of nucleocapsid was changed and bloated. The results indicated that the rALFPm3 fought against WSSV by binding to the structural proteins on the WSSV envelope and nucleocapsid leading to the Fig. 4 . Localization of WSSV186 and WSSV471 on WSSV virions. Triton X-100 treatment was used to fractionate the WSSV virions into envelope and nucleocapsid protein fractions. Both fractions were separated on 12.5% coomassie blue stained-SDSePAGE and Western blotting using the purified polyclonal antibody specific to WSSV186 and WSSV471 (A). In addition, IEM was performed using the purified anti-WSSV186 or anti-WSSV471 antibody as a primary antibody and a gold-labeled secondary antibody to detect WSSV186 or WSSV471 on the WSSV virions. As compared to the control using pre-immune serum where the gold particle was undetectable, the positive signals were observed on the nucleocapsid for WSSV186 and envelope for WSSV471 of the virions as indicated by black arrows (B). Letters E and N indicate intact virions and nucleocapsid, respectively. instability of envelope and nucleocapsid structures and breaking up the WSSV virions.
Discussion
The antimicrobial protein ALFPm3 displays broad activity against bacteria, fungi and viruses especially the marine pathogens V. harveyi (Somboonwiwat et al., 2005) , V. parahaemolyticus AHPND causing early mortality syndrome (Supungul et al., 2015) and WSSV (Tharntada et al., 2009) . While the mode of action of ALFPm3 on V. harveyi has been known through bacterial membrane permeabilization as shown by damaged morphological structure of bacterial cells after rALFPm3 treatment (Jaree et al., 2012) , that of ALFPm3 on WSSV still needs to be explored. Previously, the yeast two-hybrid experiment showed that ALFPm3 interacts with five WSSV proteins namely WSSV186, WSSV189, WSSV395, WSSV458, and WSSV471. Our previous study has confirmed that ALFPm3 interacts with WSSV189 providing a clue to our understanding of how ALFPm3 acts on WSSV (Suraprasit et al., 2014) . The genuine interactions between ALFPm3 and all WSSV-interacting proteins, however, need to be confirmed to elucidate the antiviral mechanisms of ALFPm3. In this study, the recombinant proteins of WSSV186, WSSV395, WSSV458, and WSSV471 were successfully produced and purified. The interactions between ALFPm3 and these WSSV proteins were investigated by the pull-down assay. It was found that all five WSSV proteins, WSSV186, WSSV189, WSSV395, WSSV458, and WSSV471 interact specifically with ALFPm3.
About 40 WSSV proteins have been previously characterized. Most of these proteins are structural proteins in the envelope, tegument and nucleocapsid. Some WSSV proteins that act as nonstructural proteins are involved in transcriptional regulation, virus proliferation and regulation of DNA replication (EscobedoBonilla et al., 2008) . In 2004, liquid chromatographyenano-electrospray ionization tandem mass spectrometry (LC-nanoESI-MS/ MS) was performed to identify WSSV proteins (Tsai et al., 2004) . They found 39 structural proteins of WSSV including WSSV395. A shotgun proteomic study of WSSV revealed that the WSSV186 and WSSV189 are WSSV structural proteins (Li et al., 2007) . Western blot analysis and immunoelectron microscopy showed that WSSV395 and WSSV189 are envelope proteins and WSSV458 is a tegument protein of WSSV (Jaree et al., 2016; Suraprasit et al., 2014; Zhu et al., 2006) . Herein, we showed that WSSV186 and WSSV471 are located at the nucleocapsid and envelope parts of WSSV, respectively. All five WSSV proteins that interact with ALFPm3 are, therefore, structural proteins of WSSV.
Interactions between the structural proteins are typically found in enveloped viruses. The viral proteins might form complexes that have specific roles in host-viral interactions or the infectivity of viruses. The membrane-associated model of WSSV structural protein complex, called an infectome, has already been identified, where VP24 acts as a core protein that is conjugated with other WSSV structural proteins. This infectome is believed to play a role in cell recognition and might be involved in viral entry mechanism (Chang et al., 2010) . In case of host-viral protein interaction, the relationship between shrimp chitin binding protein (CBP) and the envelope protein complex including VP24, VP28, VP31, VP32 VP39B, VP53A, and VP56, was recently investigated and shown that CBP plays an important role in virus attachment . According to our findings and data from the proteinprotein interaction network of WSSV constructed by Sangsuriya et al., 2014 , it is possible that these five ALFPm3-interacting proteins interact with each other forming a complex that is the target molecule of ALFPm3. Therefore, the proposed model of the ALFPm3-interacting protein complex composing of the envelope core protein, WSSV395, and other envelope, tegument, and nucleocapsid proteins was constructed (Fig. 5) . Further research, however, is required to confirm this tentative model.
To date, no data have demonstrated a clear relationship between the structural groups of an antimicrobial peptide (AMP) and its mode of action, the degree of activity, or the host range. The structure, size, charge, hydrophobicity, amphipathicity, and solubility are all crucial for the antimicrobial activities and target specificity of AMPs (Bahar and Ren, 2013) . The 3D structure of ALFPm3 contains three a-helices packed against four strands of bsheet. By comparative molecular modeling, the hypothetical LPSbinding domain consists of six positively charged amino acid residues (four Lys and two Arg) (Yang et al., 2009 ) (Suraprasit et al., 2014) and (Glu 27 -Glu 28 -Glu 29 -Glu 30 ), respectively. We hypothesized that, if the negatively charged residues of WSSV189 and WSSV471 located on the protein surface, the ALFPm3 would interact with them via electrostatic interaction. However, how ALFPm3 interacts with each WSSV protein-interacting partner should be further investigated. The cationic antiviral peptides have several mechanisms that can prevent viral infection including blocking of viral entry into the cell, suppression of cell fusion, suppression of viral gene expression, inhibition of peptide chain elongation, binding of peptides to viral proteins causing inhibition of adsorption or virus-cell fusion, and activation of an immune modulatory pathway (Mulder et al., 2013) . Our results indicated that each of ALFPm3 interacting WSSV protein hindered the neutralizing ALFPm3 antiviral activity resulting in lower shrimp survival. Moreover, the neutralization activity assay showed the independent interaction between ALFPm3 and each WSSV protein. TEM micrographs also showed that the purified-WSSV virions incubated with ALFPm3 have undergone a morphological change on their envelope and nucleocapside parts. Hence, we concluded that the ALFPm3 directly interacts with a complex of structural proteins on the WSSV virions and prevents the WSSV infection in shrimp.
In conclusion, ALFPm3 exhibits antiviral activity against WSSV by binding to the complex of WSSV structural proteins and causes severe damages on the integrity of WSSV virions, which in turn reduces the infectivity of WSSV. Consequently, ALFPm3 is a highly potent immune molecule in the defense against WSSV infection, and can potentially be applied for disease control in aquaculture.
